Lung Neoplasms  >>  Pulmicort Turbuhaler (budesonide dry-powder inhaler)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pulmicort Turbuhaler (budesonide dry-powder inhaler) / AstraZeneca
NCT00005880: Budesonide in Treating Former and Current Smokers With Bronchial Dysplasia

Completed
2
Canada
budesonide
British Columbia Cancer Agency, National Cancer Institute (NCI)
Lung Cancer
 
 

Download Options